July 11 – 12, 2011. SMi’s BioBanking is the perfect opportunity to network with the industry’s leading figures and contribute to the successful future of drug discovery. With a key focus on bridging the gap between the world’s leading academia and the pharma industry, biobanking provides the perfect forum to successfully build essential frameworks for future research and drug development.
Developing communication frameworks between academics and pharmaceutical companies should not be underestimated as R&D undertaken by leading academics delivers huge value and importance to future drug development. It is in the commercial interest of leading pharmaceutical companies to build frameworks to not only harmonise and standardize biobanks on a global scale, but to ensure communication between universities and pharma are in place. By working together and understanding each other’s needs will mean the quality and diversity of samples and research will attract continual financial rewards for future drug development.